Page 8 of 19 · 436 questions tagged vendor-vetting.
What I have: SGN · retatrutide. I have a result I cannot explain, and I would rather diagnose it than guess. I have checked the obvious explanations and eliminated…
For reference: date of analysis · CPC. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The particulars: liraglutide · chromatogram. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
What I have: WWB · retatrutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am interested in…
The particulars: 98.2% · ecnoglutide · SWB. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
The specifics, since they change the answer: oral semaglutide · list of related substances. I want to understand what this actually establishes, as opposed to what it…
What I have: KP · orforglipron. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence exists and I…
The case in front of me: 98.2% · liraglutide · ERP. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan…
What I have: batch certificate · ERP. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Stated plainly: 98.2% · mazdutide · QST. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided the…
What I am working with: BCH · Shanghai Sigma-Audley. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
The method section is present, which is unusual enough that I want to make use of it. I am trying to do this correctly the first time rather than learn it by getting…
Two things I have been told confidently and suspect are both wrong. First, that suppliers ask for crypto "because it is untraceable". That cannot be right for a…
What I have: SGN · Bachem Holding (Suzhou). I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
The method section is present, which is unusual enough that I want to make use of it. I have done this once and I suspect I got away with it rather than got it right.…
Conditions: QST · liraglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs without…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I have the document in front of me and I can read the numbers. What I cannot…
Stated plainly: BCH · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched the…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I have done this once and I suspect I got away with it rather than got…
Stated plainly: WXT · Shanghai Sigma-Audley. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
What I am working with: 96.4% · cagrilintide · CPC. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…
The lane and the lead time matter as much as the material for what I am doing. I would like to define my thresholds before I have a result, for obvious reasons. I…
This is my second independent submission on material from the same supplier. I understand the observation; what I do not understand is the mechanism behind it. I have…
Setup, so nobody has to ask: orforglipron · sampling plan. I have read the primary source rather than the summary, which has left me with more questions. I understand…